Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Narcolepsy Therapeutics Market

Narcolepsy Therapeutics Market Share

Report ID: GMI10260
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Narcolepsy Therapeutics Market Share

The narcolepsy therapeutics industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel therapeutics with improved efficiency and cost-effectiveness are key market strategies for narcolepsy medicines manufacturers, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for novel narcolepsy therapeutics.

Narcolepsy Therapeutics Market Companies

Some of the eminent market participants operating in the industry include:

Avadel Pharmaceuticals
Axsome Therapeutics Inc.
Harmony Biosciences
Jazz Pharmaceuticals PLC
Mylan N.V.
Novartis AG
Rhodes Pharmaceuticals L.P.
Shionogi Inc.
Takeda Pharmaceutical Company
Teva Pharmaceuticals Industries Ltd
XWPharma Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global industry size for narcolepsy therapeutics was valued at USD 3.6 billion in 2023 and is anticipated to register 8.2% CAGR between 2024 and 2032 due to the introduction of novel therapeutic products and advancements in R&D activities

The retail pharmacies segment in the narcolepsy therapeutics market held 48.6% revenue share in 2023 driven by their widespread accessibility and recommended over-the-counter products for narcolepsy management.

North America market size accounted for USD 1.6 billion in 2023, owing to the increased awareness among the public and healthcare professionals from campaigns and educational initiatives.

Avadel Pharmaceuticals, Axsome Therapeutics Inc., Harmony Biosciences, Jazz Pharmaceuticals PLC, Mylan N.V., Novartis AG, Rhodes Pharmaceuticals L.P., Shionogi Inc., and Takeda Pharmaceutical Company, among others.